Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week
Published in Dermatology

Journal Scan / Research · July 17, 2023

Major Adverse Cardiovascular Events in Patients Treated With Oral JAK Inhibitors for Atopic Dermatitis

The British Journal of Dermatology


Additional Info

The British Journal of Dermatology
Major adverse cardiovascular events in patients treated with oral Janus kinase inhibitors for atopic dermatitis: a systematic review and meta-analysis
Br J Dermatol 2023 Jul 06;[EPub Ahead of Print], C Ertus, LM Scailteux, A Lescoat, P Berthe, V Auffret, A Dupuy, E Oger, C Droitcourt

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading